Montis Capital

Overview

Montis Capital is a Warsaw-based venture capital firm specializing in financing hardware, software, deep tech, and climate tech companies across Poland. The firm focuses on sectors such as Industry 4.0 and Life Science, aiming to support innovative and market-validated products with scalable business models. Montis Capital seeks to collaborate with exceptional teams to provide expansion and growth capital. The firm's investment strategy targets companies in the early stages of development, including Seed, Early Stage, Series A, Series B, and Growth stages. Montis Capital typically invests between €1.5 million and €5 million, acquiring minority stakes ranging from 10% to 49%. The firm aims for a minimum fivefold return on investment over a 5-7 year horizon. Its geographical focus is primarily on Poland, with a diverse industry focus encompassing technology, healthcare, energy, ICT, biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, cosmeceuticals, food processing, environmental devices, biomedical devices, robotics, artificial intelligence, internet of things, big data, and deep tech. Montis Capital's team comprises experienced professionals with backgrounds in investment management, finance, and technology. The firm's leadership includes Łukasz Dziekoński, the CEO and co-founder, who has a history of involvement in infrastructure and new technologies investments. Tomasz Poniński, the managing partner, has been active in early-stage investments in life science, energy, and ICT sectors. Wojciech Szwankowski, the CFO, has experience in investment banking and private equity. The firm has made notable investments in companies such as Talkin Things, Skriware, Biotts, PlumResearch, FreshInset, and Proteon Pharmaceuticals.